Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Yiquan Huang,Zhuoshan Huang,Aiwen Lin,Shaozhao Zhang,Lianxiong Yuan,Yang Chen,Jinlai Liu,Odong Christopher,Xinxue Liao,Xiaoxian Qian,Xiaodong Zhuang,Qiang Jie,Leile Tang,Suhua Li,Longgen Xiong,Yesheng Ling,Zhenyu Xiong,Bingyuan Wu

doi:10.1136/bmjopen-2023-072541

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Yiquan Huang, Zhuoshan Huang + Show 16 more

Open Access

https://doi.org/10.1136/bmjopen-2023-072541

Copy DOI

Journal: BMJ Open	Publication Date: Jul 1, 2023
Citations: 1	License type: CC BY-NC 4.0

Affiliation: First Affiliated Hospital of Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University, Panyu District Central Hospital, Second Affiliated Hospital of Guangzhou Medical University

#Periprocedural Myocardial Injury In Patients #Myocardial Injury In Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionPercutaneous coronary intervention (PCI)-related myocardial infarction (type 4a MI) and major periprocedural myocardial injury have been demonstrated leading to poor prognosis of patients with coronary heart disease (CHD) undergoing elective...

Full Text